Authors:
Iyengar, RV
Pawlik, CA
Krull, EJ
Phelps, DA
Burger, RA
Harris, LC
Potter, PM
Danks, MK
Citation: Rv. Iyengar et al., Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression, CANCER RES, 61(7), 2001, pp. 3045-3052
Authors:
Meck, MM
Wierdl, M
Wagner, LM
Burger, RA
Guichard, SM
Krull, EJ
Harris, LC
Potter, PM
Danks, MK
Citation: Mm. Meck et al., A virus-directed enzyme prodrug therapy approach to purging neuroblastoma cells from hematopoietic cells using adenovirus encoding rabbit carboxylesterase and CPT-11, CANCER RES, 61(13), 2001, pp. 5083-5089
Authors:
Pawlik, CA
Iyengar, RV
Krull, EJ
Mason, SE
Khanna, R
Harris, LC
Potter, PM
Danks, MK
Guichard, SM
Citation: Ca. Pawlik et al., Use of the ornithine decarboxylase promoter to achieve N-MYC-mediated overexpression of a rabbit carboxylesterase to sensitize neuroblastoma cells toCPT-11, MOL THER, 1(5), 2000, pp. 457-463
Authors:
Danks, MK
Morton, CL
Krull, EJ
Cheshire, PJ
Richmond, LB
Naeve, CW
Pawlik, CA
Houghton, PJ
Potter, PM
Citation: Mk. Danks et al., Comparison of activation of CPT-11 by rabbit and human carboxylesterases for use in enzyme/prodrug therapy, CLIN CANC R, 5(4), 1999, pp. 917-924
Authors:
Guichard, SM
Morton, CL
Krull, EJ
Stewart, CF
Danks, MK
Potter, PM
Citation: Sm. Guichard et al., Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase, CLIN CANC R, 4(12), 1998, pp. 3089-3094